CAG Repeats and Personalized TRT: Why We Treat the Patient, Not Just the Numbers
Medically reviewed by Dr. Michael Koehler, MD
At Affinity Whole Health, we believe testosterone replacement therapy (TRT) should be as individual as the men who receive it. While lab values provide essential guidance, they don’t tell the whole story. One powerful genetic factor that explains why two men with nearly identical testosterone levels can experience very different symptoms - and respond differently to treatment - is the CAG repeat polymorphism in the androgen receptor (AR) gene.
This genetic variation underscores why we prioritize treating the patient (their symptoms, quality of life, and overall well-being) while still rigorously respecting laboratory data for safety and optimization.
What Are CAG Repeats?
The androgen receptor gene contains a stretch of repeated DNA sequences called CAG repeats in exon 1. These repeats code for a polyglutamine tract in the receptor protein. The number of repeats typically ranges from about 9 to 36 in the general population, with an average around 20–22.
• Shorter CAG repeats (< 20–22) are associated with greater androgen receptor sensitivity. The receptor responds more robustly to testosterone.
• Longer CAG repeats (> 23–25) are linked to reduced receptor sensitivity. More testosterone is often needed to achieve the same biological effect.
This is not a disease - it’s normal genetic variation that acts like a “volume knob” on how strongly testosterone signals in tissues such as muscle, bone, brain, prostate, and sexual function.
Evidence: How CAG Repeats Influence Testosterone Action and Symptoms
Multiple peer-reviewed studies demonstrate that CAG repeat length modulates the relationship between circulating testosterone and clinical outcomes.
A 2021 study published in the Journal of Sexual Medicine found a significant interaction between testosterone levels and AR-CAG repeat length on vitality (measured by SF-36). Men with shorter CAG repeats were more likely to report symptoms of low testosterone (fatigue, low energy) when their testosterone declined. In contrast, men with longer repeats showed a different pattern, highlighting that the same testosterone level does not produce equivalent effects across individuals.
Research by Zitzmann and colleagues has consistently shown that longer CAG repeats are associated with reduced transcriptional activity of the androgen receptor. This leads to weaker androgen effects at any given testosterone concentration. Their work in pharmacogenetics of TRT demonstrates that CAG length influences both the efficacy and safety profile of testosterone therapy, including metabolic responses and prostate changes.
In clinical cohorts of men with late-onset hypogonadism (LOH), longer CAG repeats have been linked to more severe symptoms on validated scales such as the Aging Males’ Symptoms score, even when total testosterone levels were comparable. One analysis noted that men with LOH had significantly longer CAG repeats compared to those without, and longer repeats correlated with higher symptom burden.
A key 2007 study in the Journal of Clinical Endocrinology & Metabolism showed that CAG repeat length and body mass index together modulate the safety and metabolic benefits of long-term testosterone undecanoate therapy in hypogonadal men. Shorter CAG repeats were associated with greater improvements in certain parameters, reinforcing that genetic sensitivity affects how well TRT works.
More recently, clinical research exploring the use of testosterone-to-CAG ratios (rather than testosterone levels alone) has shown improved correlation with hypogonadal symptoms, suggesting that incorporating CAG length provides a more nuanced assessment than labs in isolation.
These findings are not theoretical - they explain real-world observations in TRT clinics: some men feel dramatically better at mid-normal testosterone levels, while others may continue to report fatigue, low libido, or mood issues until levels are optimized higher (within safe physiologic ranges).
Why We Focus on Treating the Patient, Not Just the Numbers
Lab values (total testosterone, free testosterone, estradiol, hematocrit, PSA, etc.) are critical. They help us:
• Confirm the diagnosis
• Guide initial dosing
• Monitor safety
• Track progress objectively
However, symptoms matter most to the patient. There is individual variation at different testosterone levels in men. CAG repeat length is one reason for this discordance. It means the “optimal” testosterone level is not universal - it is individualized by genetics, SHBG levels, age, comorbidities, and lifestyle.
Testing for CAG Repeats: Challenges in Clinical Practice
While CAG repeat length can be measured through specialized genetic testing of the androgen receptor gene, this testing is not routinely performed or readily available in everyday clinical practice for TRT management.
Several practical barriers exist:
• It requires sending samples to specialized laboratories, which adds cost and turnaround time.
• Results require nuanced expert interpretation and do not provide a simple “target number” or automatic dosing formula.
• There is currently no standardized clinical guideline recommending routine CAG testing for TRT optimization.
For these reasons, at Affinity Whole Health we primarily guide TRT by focusing on symptom relief - how the patient feels in terms of energy, mood, libido, erectile function, body composition, motivation, and overall quality of life - while closely monitoring laboratory values for safety and efficacy.
We view CAG repeat length as an important conceptual explanation for individual variability rather than a test we rely on for most patients. This patient-centered approach allows us to optimize therapy effectively without depending on specialized genetic testing that is difficult to obtain and interpret in routine practice.
Our Personalized Approach at Affinity Whole Health
We respect that every man’s androgen receptor sensitivity is unique. That’s why our TRT programs are never one-size-fits-all. We:
• Start with thorough evaluation of symptoms and labs
• Use physiologic dosing aimed at symptom resolution within safe ranges
• Monitor regularly and adjust based on both how the patient feels and objective data
• Stay current with genetic and pharmacogenetic research to refine care
The understanding of factors like CAG repeats continues to validate what experienced clinicians have observed for years: successful TRT requires balancing science (labs and individual biology) with the art of medicine (listening to the patient).
Ready to explore a truly individualized approach to TRT?
If you’re experiencing symptoms of low testosterone or want to optimize your current therapy with a focus on both labs and how you actually feel, we’re here to help.
Schedule a consultation with our team at Affinity Whole Health to discuss a personalized plan tailored to your unique biology and goals.
Important Disclaimer: This blog post is for educational purposes only and does not constitute medical advice. CAG repeat testing is not routine for all patients and should only be considered in specific clinical contexts under the guidance of a qualified physician. Individual responses to TRT vary widely. Always consult with your healthcare provider for personalized evaluation and treatment.